Artificial intelligence is poised to rapidly reshape many fields, including that of skin cancer
screening and diagnosis, both as a disruptive and assistive technology. Together with the …

Biomarkers help to inform the clinical management of patients with melanoma. For patients
with clinically localised primary melanoma, biomarkers can help to predict post-surgical …

In this issue of JAMA Dermatology, Patel and colleagues1 examine mortality after a
diagnosis of melanoma in situ. Melanoma in situ is the earliest stage of melanoma (stage 0) …

Methods Using hyperspectral imaging (HSI) and spectral phasor analysis, we investigated
autofluorescence patterns in melanoma compared to intradermal nevi. Using UV excitation …

Melanoma mortality has declinedover the past decade, largely due to availability of
dramatically more effective treatments of advanced disease, 1 but melanoma remains an …

Aims To make recommendations on managing the surveillance of patients with stage I, II, III
or resectable IV melanoma who are clinically free of disease following treatment with …

Objectives: This study addresses the knowledge gap on optimal frequency of skin self-
examinations (SSE) for skin cancer prevention in the United States. Our results offer …

Melanoma skin cancer develops in the melanocyte cells of the skin. Although melanoma
skin cancer can start in other parts of the body where melanocytes are found, these types of …

This document addresses various modalities (listed below) for the treatment of valvular
incompetence (reflux) of the great saphenous vein (GSV) or small saphenous vein …